Workflow
Tango Therapeutics(TNGX) - 2025 Q3 - Quarterly Results

update 23 October 2025 Vopimetostat clinical Disclaimer and safe harbor statement Centain statements, in this presentation may be considered forward-looking statements. Forward-i-ooking statements, Forward-i-ooking statements, Tangis's truce financial an development plans, as well as development and clinical trial oblyectives for Tang's product pipeline (as individual therapies and combination therapies with other party's d termindogy such as "may", "should", "expect", "intent","will","path","achievable","m ...